Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2024-03-15 00:00:00 ET · period of report 2024-03-13 · accession 0000914475-24-000090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-15 | 2024-03-13 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $140.14 | -3,000 | 7,507 | -29% | -$420.4K |
| D | 2024-03-15 | 2024-03-13 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $106.02 | +3,000 | 10.5K | +40% | +$318.1K |
| D | 2024-03-15 | 2024-03-13 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $106.02 | -3,000 | 4,367 | -41% | -$318.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-13 | S | D | 3,000 | $140.14 | 7,507 | D | — | — | (F2) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.20. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 2 | Common | Common Stock | 2024-03-13 | M | A | 3,000 | $106.02 | 10,507 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option | 2024-03-13 | M | D | 3,000 | $106.02 | 4,367 | D | $106.02 · — to 2031-02-01 | 3,000 Common Stock | (F3) Option granted February 1, 2021 and vests at 25% upon first anniversary (February 1, 2022) and remaining 75% vesting in 36 equal monthly installments beginning on March 1, 2022. |